Litigation Details for ZYDUS PHARMACEUTICALS (USA) INC. v. NOVARTIS PHARMACEUTICALS CORP. (D.N.J. 2019)
✉ Email this page to a colleague
ZYDUS PHARMACEUTICALS (USA) INC. v. NOVARTIS PHARMACEUTICALS CORP. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-12-10 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-02-11 |
| Cause | 28:2201 Declaratory Judgment | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 9,283,209 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ZYDUS PHARMACEUTICALS (USA) INC. v. NOVARTIS PHARMACEUTICALS CORP.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for ZYDUS PHARMACEUTICALS (USA) INC. v. NOVARTIS PHARMACEUTICALS CORP. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-12-09 | 1 | Complaint | claim of U.S. Patent No. 9,283,209 (“the ’209 patent”). Zydus brings this suit to obtain patent certainty…hereby certifies that the patent at issue in this action, U.S. Patent No. 9,283,209, is the subject of the…Declaratory Judgment of Noninfringement of U.S. Patent No. 9,283,209) 59. Zydus hereby incorporates…resolution of patent disputes by authorizing a patent owner to sue an ANDA applicant for patent infringement…with the United States Patent and Trademark Office (“USPTO”) of the ’209 patent. 6. On information | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
